JP2025157438A5 - - Google Patents
Info
- Publication number
- JP2025157438A5 JP2025157438A5 JP2025120944A JP2025120944A JP2025157438A5 JP 2025157438 A5 JP2025157438 A5 JP 2025157438A5 JP 2025120944 A JP2025120944 A JP 2025120944A JP 2025120944 A JP2025120944 A JP 2025120944A JP 2025157438 A5 JP2025157438 A5 JP 2025157438A5
- Authority
- JP
- Japan
- Prior art keywords
- use according
- pharmacopoeia
- pemphigus
- administered
- human patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962913029P | 2019-10-09 | 2019-10-09 | |
| US62/913,029 | 2019-10-09 | ||
| US201962942877P | 2019-12-03 | 2019-12-03 | |
| US62/942,877 | 2019-12-03 | ||
| PCT/US2020/054809 WO2021072095A1 (en) | 2019-10-09 | 2020-10-08 | Methods of treating pemphigus by administering (r)-2-[3-[4-amino-3-(2-fluoro-4-phenoxy-phenyl)pyrazolo[3,4-d]pyrimidin-1-yl]piperidine-1-carbonyl]-4-methyl-4-[4-(oxetan-3-yl)piperazin-1-yl]pent-2-enenitrile |
| JP2022520968A JP7784995B2 (ja) | 2019-10-09 | 2020-10-08 | （ｒ）－２－［３－［４－アミノ－３－（２－フルオロ－４－フェノキシ－フェニル）ピラゾロ［３，４－ｄ］ピリミジン－１－イル］ピペリジン－１－カルボニル］－４－メチル－４－［４－（オキセタン－３－イル）ピペラジン－１－イル］ペンタ－２－エンニトリルを投与することによる天疱瘡を処置する方法 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520968A Division JP7784995B2 (ja) | 2019-10-09 | 2020-10-08 | （ｒ）－２－［３－［４－アミノ－３－（２－フルオロ－４－フェノキシ－フェニル）ピラゾロ［３，４－ｄ］ピリミジン－１－イル］ピペリジン－１－カルボニル］－４－メチル－４－［４－（オキセタン－３－イル）ピペラジン－１－イル］ペンタ－２－エンニトリルを投与することによる天疱瘡を処置する方法 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2025157438A JP2025157438A (ja) | 2025-10-15 |
| JP2025157438A5 true JP2025157438A5 (https=) | 2026-03-30 |
Family
ID=73030241
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520968A Active JP7784995B2 (ja) | 2019-10-09 | 2020-10-08 | （ｒ）－２－［３－［４－アミノ－３－（２－フルオロ－４－フェノキシ－フェニル）ピラゾロ［３，４－ｄ］ピリミジン－１－イル］ピペリジン－１－カルボニル］－４－メチル－４－［４－（オキセタン－３－イル）ピペラジン－１－イル］ペンタ－２－エンニトリルを投与することによる天疱瘡を処置する方法 |
| JP2025120944A Pending JP2025157438A (ja) | 2019-10-09 | 2025-07-18 | （ｒ）－２－［３－［４－アミノ－３－（２－フルオロ－４－フェノキシ－フェニル）ピラゾロ［３，４－ｄ］ピリミジン－１－イル］ピペリジン－１－カルボニル］－４－メチル－４－［４－（オキセタン－３－イル）ピペラジン－１－イル］ペンタ－２－エンニトリルを投与することによる天疱瘡を処置する方法 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022520968A Active JP7784995B2 (ja) | 2019-10-09 | 2020-10-08 | （ｒ）－２－［３－［４－アミノ－３－（２－フルオロ－４－フェノキシ－フェニル）ピラゾロ［３，４－ｄ］ピリミジン－１－イル］ピペリジン－１－カルボニル］－４－メチル－４－［４－（オキセタン－３－イル）ピペラジン－１－イル］ペンタ－２－エンニトリルを投与することによる天疱瘡を処置する方法 |
Country Status (12)
| Country | Link |
|---|---|
| US (2) | US20210106583A1 (https=) |
| EP (1) | EP4041240A1 (https=) |
| JP (2) | JP7784995B2 (https=) |
| KR (1) | KR20220079909A (https=) |
| CN (1) | CN115190798A (https=) |
| AU (1) | AU2020363873A1 (https=) |
| BR (1) | BR112022005575A2 (https=) |
| CA (1) | CA3153750A1 (https=) |
| CO (1) | CO2022005949A2 (https=) |
| IL (1) | IL291726A (https=) |
| MX (1) | MX2022004283A (https=) |
| WO (1) | WO2021072095A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202535403A (zh) * | 2023-10-25 | 2025-09-16 | 美商普林斯匹亞生物製藥公司 | 藉由投予（ｒ）－２－［３－［４－胺基－３－（２－氟－４－苯氧基－苯基）吡唑並［３，４－ｄ］嘧啶－１－基］哌啶－１－羰基］－４－甲基－４－［４－（氧雜環丁烷－３－基）哌𠯤－１－基］戊－２－烯腈治療慢性自發性蕁麻疹 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ME03455B (me) | 2012-09-10 | 2020-01-20 | Principia Biopharma Inc | Jedinjenja pirazolopirimidina kao inhibitori kinaze |
| PT3107544T (pt) | 2014-02-21 | 2021-01-05 | Principia Biopharma Inc | Sais e forma sólida de um inibidor de btk |
| US10485797B2 (en) | 2014-12-18 | 2019-11-26 | Principia Biopharma Inc. | Treatment of pemphigus |
| CA2971109C (en) | 2014-12-24 | 2024-07-02 | Principia Biopharma Inc. | SITE-SPECIFIC DOSAGE OF A BTK INHIBITOR |
| MA45547A (fr) | 2016-06-29 | 2019-05-08 | Principia Biopharma Inc | Formulations à libération modifiée à base de 2-[3-[4-amino-3-(2-fluoro-4-phénoxy-phényl)pyrazolo[3,4-d]pyrimidine-1-yl]pipéridine-1-carbonyl]-4-méthyl-4-[4-(oxétane-3-yl)pipérazine-1-yl]pent-2-ènenitrile |
| WO2019208805A1 (ja) * | 2018-04-27 | 2019-10-31 | 小野薬品工業株式会社 | Ｂｔｋ阻害活性を有する化合物を有効成分として含む自己免疫疾患の予防および／または治療剤 |
-
2020
- 2020-10-08 US US17/066,300 patent/US20210106583A1/en not_active Abandoned
- 2020-10-08 BR BR112022005575A patent/BR112022005575A2/pt unknown
- 2020-10-08 EP EP20797943.6A patent/EP4041240A1/en active Pending
- 2020-10-08 AU AU2020363873A patent/AU2020363873A1/en active Pending
- 2020-10-08 WO PCT/US2020/054809 patent/WO2021072095A1/en not_active Ceased
- 2020-10-08 CA CA3153750A patent/CA3153750A1/en active Pending
- 2020-10-08 JP JP2022520968A patent/JP7784995B2/ja active Active
- 2020-10-08 MX MX2022004283A patent/MX2022004283A/es unknown
- 2020-10-08 CN CN202080083113.6A patent/CN115190798A/zh active Pending
- 2020-10-08 KR KR1020227015113A patent/KR20220079909A/ko active Pending
-
2022
- 2022-03-27 IL IL291726A patent/IL291726A/en unknown
- 2022-05-06 CO CONC2022/0005949A patent/CO2022005949A2/es unknown
- 2022-09-30 US US17/957,073 patent/US20230158033A1/en active Pending
-
2025
- 2025-07-18 JP JP2025120944A patent/JP2025157438A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW576743B (en) | Extended release formulations of erythromycin derivatives | |
| AU2018357775B2 (en) | New combination of active agents for the treatment of progressive fibrosing interstitial lung diseases (PF-ILD) | |
| JP2025157438A5 (https=) | ||
| Kooybaran et al. | Esophageal lichen planus successfully treated with the JAK1/3 inhibitor tofacitinib | |
| MX2024010637A (es) | Nuevas combinaciones terapeuticas para el tratamiento de enfermedades pulmonares intersticiales fibrosantes progresivas. | |
| McLeod et al. | Intramuscular triamcinolone acetonide in chronic severe asthma. | |
| FI4199922T3 (fi) | (1r,3s)-3-((5-syano-4-fenyylitiatsol-2-yyli)karbamoyyli)syklopentaani-1-karboksyylihappo käytettäväksi hengitystietautien hoidossa | |
| JP2022177119A5 (https=) | ||
| EP3886857B1 (en) | Montelukast for the treatment of erosive hand osteoarthritis | |
| JP2021530568A5 (https=) | ||
| JP6328856B2 (ja) | 収縮力低下随伴性排尿筋過活動改善剤 | |
| CN117180439A (zh) | 治疗出血性疾病的化合物及其组合物 | |
| JPWO2021072095A5 (https=) | ||
| CN117379423A (zh) | 依达拉奉在自闭症谱系障碍治疗中的应用 | |
| US20020198228A1 (en) | Composition and method for the treatment of respiratory desease | |
| RU2809024C2 (ru) | Монтелукаст для лечения эрозивного остеоартрита кистей рук | |
| JP6188784B2 (ja) | 炎症性および免疫性疾患の治療のための組成物 | |
| CN115025103A (zh) | 丹参酮iia磺酸钠在制备药物中的应用 | |
| JPWO2023043999A5 (https=) | ||
| CN111035763A (zh) | 一种治疗妇女更年期综合症的药物组合物 | |
| JPS5955829A (ja) | 脳内の器質性障害に起因する精神機能症状の改善・治療剤 | |
| CN121622667A (zh) | Sirt7抑制剂97491在制备治疗自身免疫性脱髓鞘疾病药物中的应用 | |
| JPWO2022101227A5 (https=) | ||
| MX2008014577A (es) | Combinaciones de erdosteina y beta-2 agonistas para el tratamiento de la enfermedad pulmonar obstructiva cronica. | |
| CN121754527A (zh) | 汉黄芩素在制备预防或治疗自身免疫性脱髓鞘疾病药物中的应用 |